Live-attenuated Yersinia pestis vaccines

被引:2
|
作者
Wang, Xiaoyi [1 ]
Zhang, Xuecan [1 ]
Zhou, Dongsheng [1 ]
Yang, Ruifu [1 ]
机构
[1] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China
关键词
live-attenuated vaccines; plague; Yersinia pestis; PNEUMONIC PLAGUE; BUBONIC PLAGUE; FUSION PROTEIN; PLASMINOGEN-ACTIVATOR; TRANSFERABLE PLASMID; PROTECTIVE IMMUNITY; PASTEURELLA-PESTIS; TRANS-TRANSLATION; RECEPTOR PROTEIN; SUBUNIT VACCINE;
D O I
10.1586/ERV.13.42
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Plague caused by Yersinia pestis is one of the most dangerous infectious diseases. There is no ideal plague vaccine available for human use, but a number of licensed killed whole-cell and live-attenuated vaccines have been available in the past. Currently, there are a number of vaccines under development, including live-attenuated, DNA and subunit vaccines, among others. This review deals with the development of live-attenuated plague vaccines. Traditionally, live-attenuated plague vaccines have been developed by multiple passages of fully virulent Y. pestis, but they have not gained general acceptance due to safety concerns. Recent attempts to construct attenuated Y. pestis strains with specifically defined mutations have opened the door for developing new candidates for live-attenuated plague vaccines, with a proper balance between safety and protective efficacy.
引用
收藏
页码:677 / 686
页数:10
相关论文
共 50 条
  • [11] Recent developments with live-attenuated recombinant paramyxovirus vaccines
    Le Bayon, Jean-Christophe
    Lina, Bruno
    Rosa-Calatrava, Manuel
    Boivin, Guy
    REVIEWS IN MEDICAL VIROLOGY, 2013, 23 (01) : 15 - 34
  • [12] Envelope exchange for the generation of live-attenuated arenavirus vaccines
    Bergthaler, Andreas
    Gerber, Nicolas U.
    Merkler, Doron
    Horvath, Edit
    Carlos de la Torre, Juan
    Pinschewer, Daniel D.
    PLOS PATHOGENS, 2006, 2 (06) : 501 - 512
  • [13] Live-Attenuated Vaccines in Pediatric Solid Organ Transplant
    Hartley, Christopher
    Thomas, Tina
    Smith, Sara Kathryn
    Karnsakul, Wikrom
    VACCINES, 2024, 12 (04)
  • [14] A live attenuated strain of Yersinia pestis KIM as a vaccine against plague
    Sun, Wei
    Six, David
    Kuang, Xiaoying
    Roland, Kenneth L.
    Raetz, Christian R. H.
    Curtiss, Roy, III
    VACCINE, 2011, 29 (16) : 2986 - 2998
  • [15] Rational Design of Live-Attenuated Vaccines against GenomeReduced Pathogens
    Nishikawa, Sayaka
    Ogawa, Yohsuke
    Shiraiwa, Kazumasa
    Nozawa, Rieko
    Nakayama, Momoko
    Eguchi, Masahiro
    Shimoji, Yoshihiro
    MICROBIOLOGY SPECTRUM, 2022, 10 (06):
  • [16] Development of Live-Attenuated Arenavirus Vaccines Based on Codon Deoptimization
    Cheng, Benson Yee Hin
    Ortiz-Riano, Emilio
    Nogales, Aitor
    de la Torre, Juan Carlos
    Martinez-Sobrido, Luis
    JOURNAL OF VIROLOGY, 2015, 89 (07) : 3523 - 3533
  • [17] Live-attenuated HIV vaccines: How safe is safe enough?
    Michael Murphey-Corb
    Nature Medicine, 1997, 3 : 17 - 18
  • [18] Viral Live-Attenuated Vaccines (LAVs): Past and Future Directions
    Tang, Yan-Dong
    Li, Yuming
    Cai, Xue-Hui
    Yin, Xin
    ADVANCED SCIENCE, 2025, 12 (03)
  • [19] Live-attenuated HIV vaccines: How safe is safe enough?
    MurpheyCorb, M
    NATURE MEDICINE, 1997, 3 (01) : 17 - 18
  • [20] Live-Attenuated Oral Vaccines to Reduce Campylobacter Colonization in Poultry
    Jeon, Byeonghwa
    Saisom, Tunchanok
    Sasipreeyajan, Jiroj
    Luangtongkum, Taradon
    VACCINES, 2022, 10 (05)